Patents/Assignees

Inozyme Pharma, Inc.

2 patents in portfolio

US12134790utility2024
Methods of Improving Cardiovascular Function and Treating Cardiovascular Disease Using a Recombinant Ectonucleotide Pyrophosphatase Phosphodiesterase (NPP1)
0 cites
USRE049529reissue2023
Methods of Treating Tissue Calcification
0 cites